Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Value Market Research | PRODUCT CODE: 2067775

Cover Image

PUBLISHER: Value Market Research | PRODUCT CODE: 2067775

Global Pharmaceutical Fluid Handling Market Size, Share, Trends & Growth Analysis Report 2026-2034

PUBLISHED:
PAGES: 324 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 3920
PDF & Excel (10-user License)
USD 4730
PDF & Excel (Corporate User License)
USD 7430

Add to Cart

The global pharmaceutical fluid handling market size is expected to reach USD 26.20 Billion in 2034 from USD 17.01 Billion in 2025, growing at a CAGR of 4.92 during 2026-2034.This market is experiencing strong growth due to increasing pharmaceutical production activities and rising demand for sterile and contamination-free manufacturing processes. Fluid handling systems play a critical role in the transfer, storage, mixing, and processing of pharmaceutical ingredients and formulations. Growing investments in biopharmaceutical manufacturing, vaccine production, and advanced drug development are driving market demand. Strict regulatory standards related to product quality and safety are further supporting adoption.

Manufacturers are increasingly implementing advanced fluid handling technologies to improve process efficiency and ensure compliance with regulatory requirements. Single-use systems, automated transfer solutions, and high-purity fluid management equipment are gaining popularity across pharmaceutical facilities. The expansion of biologics and personalized medicine production is creating additional opportunities for specialized fluid handling solutions. These trends are strengthening market growth across global pharmaceutical operations.

Future growth is expected to remain robust as pharmaceutical companies continue expanding production capacities. Technological innovations focused on automation, process monitoring, and contamination control will enhance operational efficiency. Emerging markets are witnessing rising investments in healthcare infrastructure and pharmaceutical manufacturing, creating new opportunities. Continued demand for biologics and advanced therapies will support sustained market development.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Offering

  • Equipment and Solutions
  • Services

By Tubing

  • Thermoplastic Elastomers
  • Polyvinyl Chloride
  • Silicone

By Usage

  • Cough Syrup
  • Intravenous Product
  • Complex Active Pharmaceutical Ingredients
  • Other Usage

By Application

  • Fluid Handling and Management
  • Fluid Preparation
  • Integration and Automation
  • Buffer Management
  • Other Applications

By End User

  • Biotechnology Companies
  • Pharmaceutical and Medical Companies
  • Other End Users

COMPANIES PROFILED

  • Pfizer Inc., Johnson & Johnson Pvt. Ltd., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Danaher Corporation, Gilead Sciences Inc., Amgen Inc., Parker Hannifin Corporation, Corning Incorporated, Agilent Technologies Inc., Alfa Laval AB, PerkinElmer Inc.
Product Code: VMR112110575

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PHARMACEUTICAL FLUID HANDLING MARKET: BY OFFERING 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Offering
  • 4.2. Equipment and Solutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PHARMACEUTICAL FLUID HANDLING MARKET: BY TUBING 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Tubing
  • 5.2. Thermoplastic Elastomers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Polyvinyl Chloride Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Silicone Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PHARMACEUTICAL FLUID HANDLING MARKET: BY USAGE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Usage
  • 6.2. Cough Syrup Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Intravenous Product Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Complex Active Pharmaceutical Ingredients Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Other Usage Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PHARMACEUTICAL FLUID HANDLING MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Application
  • 7.2. Fluid Handling and Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Fluid Preparation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Integration and Automation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Buffer Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.6. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PHARMACEUTICAL FLUID HANDLING MARKET: BY END USER 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End User
  • 8.2. Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Pharmaceutical and Medical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL PHARMACEUTICAL FLUID HANDLING MARKET: BY REGION 2022-2034 (USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Offering
    • 9.2.2 By Tubing
    • 9.2.3 By Usage
    • 9.2.4 By Application
    • 9.2.5 By End User
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Offering
    • 9.3.2 By Tubing
    • 9.3.3 By Usage
    • 9.3.4 By Application
    • 9.3.5 By End User
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Offering
    • 9.4.2 By Tubing
    • 9.4.3 By Usage
    • 9.4.4 By Application
    • 9.4.5 By End User
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Offering
    • 9.5.2 By Tubing
    • 9.5.3 By Usage
    • 9.5.4 By Application
    • 9.5.5 By End User
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Offering
    • 9.6.2 By Tubing
    • 9.6.3 By Usage
    • 9.6.4 By Application
    • 9.6.5 By End User
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL PHARMACEUTICAL FLUID HANDLING INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Pfizer Inc
    • 11.2.2 Johnson & Johnson Pvt. Ltd
    • 11.2.3 F. Hoffmann-La Roche AG
    • 11.2.4 Merck & Co. Inc
    • 11.2.5 AbbVie Inc
    • 11.2.6 Thermo Fisher Scientific Inc
    • 11.2.7 GlaxoSmithKline Plc
    • 11.2.8 Danaher Corporation
    • 11.2.9 Gilead Sciences Inc
    • 11.2.10 Amgen Inc
    • 11.2.11 Parker Hannifin Corporation
    • 11.2.12 Corning Incorporated
    • 11.2.13 Agilent Technologies Inc
    • 11.2.14 Alfa Laval AB
    • 11.2.15 PerkinElmer Inc
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!